Ligand validation:9ECF

B81: (3alpha,8alpha,17beta)-androst-5-ene-3,17-diol

B81 is a Ligand Of Interest in 9ECF designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9ECF_B81_F_601	85%	9%	0.07	0.934	1.91	2.57	7	16	1	0	100%	1
9ECF_B81_M_601	80%	9%	0.078	0.926	1.84	2.56	7	15	4	0	100%	1
9ECF_B81_B_601	75%	9%	0.077	0.91	1.9	2.58	7	15	1	0	100%	1
9ECF_B81_I_601	74%	9%	0.082	0.911	1.84	2.53	6	14	3	0	100%	1
9ECF_B81_N_601	71%	9%	0.101	0.92	1.86	2.58	6	16	2	0	100%	1
9ECF_B81_E_601	67%	9%	0.087	0.893	1.88	2.53	6	15	3	0	100%	1
9ECF_B81_A_601	65%	9%	0.097	0.897	1.88	2.58	7	16	1	0	100%	1
9ECF_B81_J_601	53%	9%	0.129	0.888	1.83	2.59	6	16	2	0	100%	1
9EBL_B81_B_601	70%	11%	0.091	0.908	1.71	2.5	6	15	3	0	100%	1
9EBG_B81_C_601	90%	9%	0.065	0.947	1.87	2.51	6	15	0	0	100%	1
3KLP_B81_X_328	35%	12%	0.194	0.882	2.05	1.99	11	10	4	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.